Literature DB >> 28474154

Rare etiology of severe calf pain and induration in a child with end-stage renal disease: Answers.

Gurinder Kumar1, Mohammed Khair AlGhabra2, Aman Sohal2, Baker Ayyash2, Nitin Airon2, Eihab AlKhasawneh2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28474154     DOI： 10.1007/s00467-017-3674-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  10 in total

1.  Calciphylaxis due to poor compliance in a child with end stage renal disease: a case report.

Authors:  Demet Toprak; Zelal Bircan; Ayse Sevim Gokalp
Journal:  Pediatr Int       Date:  2005-02       Impact factor: 1.524

2.  Cinacalcet for the treatment of calciphylaxis.

Authors:  Maria R Robinson; Joshua J Augustine; Neil J Korman
Journal:  Arch Dermatol       Date:  2007-02

3.  Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Authors:  Glenn M Chertow; Geoffrey A Block; Ricardo Correa-Rotter; Tilman B Drüeke; Jürgen Floege; William G Goodman; Charles A Herzog; Yumi Kubo; Gerard M London; Kenneth W Mahaffey; T Christian H Mix; Sharon M Moe; Marie-Louise Trotman; David C Wheeler; Patrick S Parfrey
Journal:  N Engl J Med       Date:  2012-11-03       Impact factor: 91.245

4.  Calciphylaxis in pediatric end-stage renal disease.

Authors:  Abubakr A Imam; Tej K Mattoo; Gaurav Kapur; David A Bloom; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2005-08-25       Impact factor: 3.714

5.  Successful treatment of calciphylaxis with pamidronate.

Authors:  Nakysa Hooman; Rama Naghshi-Zadiyan; Mitra Mehrazma; Fariba Jahangiri
Journal:  Iran J Kidney Dis       Date:  2015-01       Impact factor: 0.892

6.  Sodium thiosulfate in the treatment of calciphylaxis.

Authors:  George F Cohen; Nikki S Vyas
Journal:  J Clin Aesthet Dermatol       Date:  2013-05

Review 7.  Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.

Authors:  Vincent M Brandenburg; Smeeta Sinha; Paula Specht; Markus Ketteler
Journal:  Pediatr Nephrol       Date:  2014-01-29       Impact factor: 3.714

8.  Sodium thiosulfate treatment for calcific uremic arteriolopathy in children and young adults.

Authors:  Carlos E Araya; Robert S Fennell; Richard E Neiberger; Vikas R Dharnidharka
Journal:  Clin J Am Soc Nephrol       Date:  2006-08-30       Impact factor: 8.237

9.  Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages.

Authors:  M G Cecchini; R Felix; H Fleisch; P H Cooper
Journal:  J Bone Miner Res       Date:  1987-04       Impact factor: 6.741

10.  Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data.

Authors:  Hermann Salmhofer; Michael Franzen; Wolfgang Hitzl; Josef Koller; Bernhard Kreymann; Falko Fend; Cornelia Hauser-Kronberger; Uwe Heemann; Frieder Berr; Christoph Schmaderer
Journal:  Kidney Blood Press Res       Date:  2013-09-22       Impact factor: 2.687
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.